Dynavax Technologies Corporation news

   Watch this stock
Showing stories 11 - 20 of about 88   

Articles published

DVAX 1.64 -0.05 (-2.96%)
price chart
Moving Stocks: United Parcel Service(NYSE:UPS), Dynavax Technologies ...
Dynavax Technologies Corporation (NASDAQ:DVAX) on 14 October announced that it will initiate a phase I/II clinical trial, LYM-01, to assess the safety and preliminary efficacy of its pipeline candidate, SD-101.
Could You Benefit From A Hemp Inc(OTCMKTS:HEMP), RadioShack ...  GSPInsider
Related articles »  
Consumer Stocks under Investors Focus: Dynavax Technologies Corporation ...
Dynavax Technologies Corporation (NASDAQ: DVAX) declared that Dino Dina, M.D, has resigned from the BOD. Dr. Dina was a director of the Organization since 1997 and was the Company's CEO between 1998 and 2013.
News Buzz -Dynavax Technologies Corporation (NASDAQ:DVAX), Civeo Corp ...  Techsonian (press release)
Stocks in Hot Move- Caterpillar Inc. (NYSE:CAT), Dynavax Technologies ...  eMarketsDaily
Related articles »  
Dynavax Technologies Corporation (NASDAQ:DVAX) Commences Phase 1/2 ...
Dynavax Technologies Corporation (NASDAQ:DVAX) said that it had commenced Phase 1/2 clinical study of TLR-9 Agonist Immunotherapy.
Dynavax Initiates Phase I/II Trial on Lymphoma Candidate  Zacks.com
Dynavax Initiates Phase I/II Trial on Lymphoma Candidate - Analyst Blog  NASDAQ
Related articles »  
Dynavax Technologies Short Interest Down 4.3% in September (DVAX)
The company had revenue of $3.05 million for the quarter, compared to the consensus estimate of $2.26 million. Analysts expect that Dynavax Technologies will post $-0.34 EPS for the current fiscal year.
Related articles »  
Momentum Stocks in Focus:Dynavax Technologies Corporation (DVAX),DHT ...
Dynavax Technologies Corporation (NASDAQ:DVAX) ),reported initiation of a phase 1/2 clinical trial to assess the safety and preliminary efficacy of SD-101, an investigational Toll-like receptor (�TLR�) 9 agonist, in adults with untreated low-grade B ...
Related articles »  
Notable Movers: Dynavax Technologies Corporation (DVAX), Liquidmetal ...
Dynavax Technologies Corporation (NASDAQ:DVAX) released that initiation of a phase 1/2 clinical trial to assess the safety and preliminary efficacy of SD-101, an investigational Toll-like receptor (�TLR�) 9 agonist, in adults with untreated low-grade B ...
Stocks in Focus : Dynavax Technologies Corporation (NASDAQ:DVAX ...  Gaining Green
Why American Airlines Group Inc (NASDAQ:AAL), 3 Others Jumped ...  Markets Emerging
Related articles »  
Top Stories: Corning Inc. (NYSE:GLW), Dynavax Technologies Corporation ...
On 7 October Dynavax Technologies Corporation (NASDAQ:DVAX) announced that Dino Dina, M.D, has resigned from the Board of Directors.
Stocks in Focus - Pacific Ethanol Inc (PEIX), Dynavax Technologies Corporation ...
Dynavax Technologies Corporation (NASDAQ:DVAX) released initiation of a phase 1/2 clinical trial to assess the safety and preliminary efficacy of SD-101, an investigational Toll-like receptor (�TLR�) 9 agonist, in adults with untreated low-grade B-cell ...
Related articles »  
Short Interest in Dynavax Technologies Decreases By 4.3% (DVAX)
Dynavax Technologies (NASDAQ:DVAX) opened at 1.44 on Thursday. Dynavax Technologies has a 1-year low of $1.10 and a 1-year high of $2.14.
Trader's Watch List: Dynavax Technologies Corporation (DVAX), Interface ...  Techsonian (press release)
Related articles »  
Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca ...
Boston, MA 10/14/2014 (wallstreetpr) - Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1/2 clinical trials of its drug candidate SD-101.